Paraguay Drug Patents
Drug Patents in Paraguay and US Equivalents
| Patent Number | Estimated Expiration | Equivalent US Patent | US Expiry Date | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|---|---|
| 09012363 | ⤷ Start Trial | 8410167 | 2029-04-16 | dronedarone hydrochloride | Sanofi Aventis Us | MULTAQ |
| 09012363 | ⤷ Start Trial | 9107900 | 2029-04-16 | dronedarone hydrochloride | Sanofi Aventis Us | MULTAQ |
| 0715680 | ⤷ Start Trial | 8324225 | 2028-06-17 | ribociclib succinate | Novartis | KISQALI |
| 0715680 | ⤷ Start Trial | 8324225 | 2028-06-17 | letrozole; ribociclib succinate | Novartis | KISQALI FEMARA CO-PACK (COPACKAGED) |
| 1454647 | ⤷ Start Trial | 10231964 | 2034-07-02 | bupropion hydrochloride; naltrexone hydrochloride | Nalpropion | CONTRAVE |
| 1256476 | ⤷ Start Trial | 8889159 | 2029-09-26 | sofosbuvir; velpatasvir | Gilead Sciences Inc | EPCLUSA |
| 1256476 | ⤷ Start Trial | 8889159 | 2029-09-26 | ledipasvir; sofosbuvir | Gilead Sciences Inc | HARVONI |
| >Patent Number | >Estimated Expiration | >Equivalent US Patent | >US Expiry Date | >Generic Name | >US Applicant | >US Tradename |
